23andMe has rolled out a health hub where its customers can share information about their management of 18 common health conditions, according to Wired.

Unlike the reports that the company is most known for, the hub doesn't provide information on the likelihood that a person's genes will result in them having, for example, depression or allergies. Rather, the conditions and how they are being treated are self-reported by 23andMe's customers.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that researchers in Italy are testing a gene drive aimed at controlling mosquito populations.

Researchers may experience the effects of the government shutdown for a while, the Los Angeles Times reports.

A new study finds that the majority of patients at a Tijuana clinic received a diagnosis after first-line genome sequencing, the San Diego Union-Tribune reports.

In Genome Biology this week: post-transcriptional modification-based stratification of glioblastoma, single-cell analysis of gene expression and methylation in human iPSCs, and more.